SOURCE: Antisoma plc

February 02, 2010 07:01 ET

Antisoma to present at 12th Annual BIO CEO & Investor Conference in New York

LONDON and CAMBRIDGE, MA--(Marketwire - February 2, 2010) - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that Daniel Elger, VP Marketing & Communications, will present an overview of the Company's strategy, programmes and prospects at the 12th Annual BIO CEO & Investor Conference in New York on Monday, 8th February at 8:30am EST/1:30pm GMT.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.


Alison Saville

Senior Marketing and Communications Executive

Antisoma plc

+44 (0)20 3249 2144

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.

Contact Information